These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 27271678)

  • 1. Aspergillus Biofilms in Human Disease.
    Williams C; Rajendran R; Ramage G
    Adv Exp Med Biol; 2016; 931():1-11. PubMed ID: 27271678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Updates on Therapeutic Strategies Against Candida (and Aspergillus) Biofilm Related Infections.
    Muakkassa FK; Ghannoum M
    Adv Exp Med Biol; 2016; 931():95-103. PubMed ID: 27287466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspergillus biofilms: clinical and industrial significance.
    Ramage G; Rajendran R; Gutierrez-Correa M; Jones B; Williams C
    FEMS Microbiol Lett; 2011 Nov; 324(2):89-97. PubMed ID: 22092808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aspergillus fumigatus biofilms: Toward understanding how growth as a multicellular network increases antifungal resistance and disease progression.
    Morelli KA; Kerkaert JD; Cramer RA
    PLoS Pathog; 2021 Aug; 17(8):e1009794. PubMed ID: 34437655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of a novel compound, Mul-1867, against clinically significant fungi Candida spp. and Aspergillus spp.
    Tetz G; Cynamon M; Hendricks G; Vikina D; Tetz V
    Int J Antimicrob Agents; 2017 Jul; 50(1):47-54. PubMed ID: 28457835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspergillus fumigatus biofilms in the clinical setting.
    Müller FM; Seidler M; Beauvais A
    Med Mycol; 2011 Apr; 49 Suppl 1():S96-S100. PubMed ID: 21254964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aspergillus species intrinsically resistant to antifungal agents.
    Van Der Linden JW; Warris A; Verweij PE
    Med Mycol; 2011 Apr; 49 Suppl 1():S82-9. PubMed ID: 20662634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of caspofungin against Aspergillus terreus.
    Barchiesi F; Spreghini E; Santinelli A; Fothergill AW; Fallani S; Manso E; Pisa E; Giannini D; Novelli A; Cassetta MI; Mazzei T; Rinaldi MG; Scalise G
    Antimicrob Agents Chemother; 2005 Dec; 49(12):5133-5. PubMed ID: 16304185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antifungal activity of Myriocin on clinically relevant Aspergillus fumigatus strains producing biofilm.
    Perdoni F; Signorelli P; Cirasola D; Caretti A; Galimberti V; Biggiogera M; Gasco P; Musicanti C; Morace G; Borghi E
    BMC Microbiol; 2015 Oct; 15():248. PubMed ID: 26519193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Epidemiologic study of drug-resistant Aspergillus and optimizing newer treatment].
    Izumikawa K
    Jpn J Antibiot; 2011 Feb; 64(1):27-34. PubMed ID: 21612041
    [No Abstract]   [Full Text] [Related]  

  • 11. Experimental pulmonary aspergillosis due to Aspergillus terreus: pathogenesis and treatment of an emerging fungal pathogen resistant to amphotericin B.
    Walsh TJ; Petraitis V; Petraitiene R; Field-Ridley A; Sutton D; Ghannoum M; Sein T; Schaufele R; Peter J; Bacher J; Casler H; Armstrong D; Espinel-Ingroff A; Rinaldi MG; Lyman CA
    J Infect Dis; 2003 Jul; 188(2):305-19. PubMed ID: 12854088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fungal biofilm architecture produces hypoxic microenvironments that drive antifungal resistance.
    Kowalski CH; Morelli KA; Schultz D; Nadell CD; Cramer RA
    Proc Natl Acad Sci U S A; 2020 Sep; 117(36):22473-22483. PubMed ID: 32848055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update on antifungal drug resistance mechanisms of Aspergillus fumigatus.
    Chamilos G; Kontoyiannis DP
    Drug Resist Updat; 2005 Dec; 8(6):344-58. PubMed ID: 16488654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro analyses, animal models, and 60 clinical cases of invasive Aspergillus terreus infection.
    Steinbach WJ; Perfect JR; Schell WA; Walsh TJ; Benjamin DK
    Antimicrob Agents Chemother; 2004 Sep; 48(9):3217-25. PubMed ID: 15328076
    [No Abstract]   [Full Text] [Related]  

  • 15. Previously unknown species of Aspergillus.
    Gautier M; Normand AC; Ranque S
    Clin Microbiol Infect; 2016 Aug; 22(8):662-9. PubMed ID: 27263029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic aspergillus infections of the respiratory tract: diagnosis, management and antifungal resistance.
    Izumikawa K; Takazono T; Kohno S
    Curr Opin Infect Dis; 2010 Dec; 23(6):584-9. PubMed ID: 20827190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Susceptibility testing in Aspergillus species complex.
    Lass-Flörl C
    Clin Microbiol Infect; 2014 Jun; 20 Suppl 6():49-53. PubMed ID: 24372722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aspergillus--classification and antifungal susceptibilities.
    Buzina W
    Curr Pharm Des; 2013; 19(20):3615-28. PubMed ID: 23278534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biofilms and Antifungal Susceptibility Testing.
    Simitsopoulou M; Chatzimoschou A; Roilides E
    Methods Mol Biol; 2016; 1356():183-97. PubMed ID: 26519074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental efficacy of anidulafungin against Aspergillus terreus species complex.
    Sanchis M; Capilla J; Mayayo E; Pastor FJ; Guarro J
    Med Mycol; 2015 Aug; 53(6):630-5. PubMed ID: 25980004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.